The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease.

The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease.

Previous work has shown an association between the K variant of the butyrylcholinesterase (BCHE) gene and Alzheimer's disease (AD) in patients carrying the epsilon4 allele of ApoE. We attempted to replicate this finding in 181 UK white AD cases and 71 controls. No difference was found in BCHE-K...

תיאור מלא

מידע ביבליוגרפי
Main Authors:	Kehoe, P, Williams, H, Holmans, P, Wilcock, G, Cairns, N, Neal, J, Owen, M
פורמט:	Journal article
שפה:	English
יצא לאור:	1998

פריטים דומים

Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease.
מאת: Kehoe, P, et al.
יצא לאור: (1999)

Association between a PS-1 intronic polymorphism and late onset Alzheimer's disease.
מאת: Kehoe, P, et al.
יצא לאור: (1996)

Onset of Alzheimer disease in apolipoprotein ɛ4 carriers is earlier in butyrylcholinesterase K variant carriers
מאת: Roger M. Lane, et al.
יצא לאור: (2024-04-01)

Presenilin-1 polymorphism and Alzheimer's disease. The UK Alzheimer's Disease Collaborative Group.
מאת: Kehoe, P, et al.
יצא לאור: (1996)

Association of butyrylcholinesterase K variant with cholinesterase-positive neuritic plaques in the temporal cortex in late-onset Alzheimer's disease.
מאת: Lehmann, D, et al.
יצא לאור: (2000)

Presenilin-1 polymorphism and Alzheimer's disease [6]
מאת: Kehoe, P, et al.
יצא לאור: (1996)

Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation.
מאת: Holmes, C, et al.
יצא לאור: (2005)

Common variants of ACE contribute to variable age-at-onset of Alzheimer's disease.
מאת: Kehoe, P, et al.
יצא לאור: (2004)

ApoE epsilon 2 and butyrylcholinesterase K variant are associated with coronary heart disease in type 2 diabetes
מאת: Horton, V, et al.
יצא לאור: (2000)

Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain.
מאת: Blomqvist, M, et al.
יצא לאור: (2005)

Butyrylcholinesterase K variant is associated with type 2 diabetes in UK Caucasians
מאת: Hashim, Y, et al.
יצא לאור: (2000)

Association between butyrylcholinesterase K variant and mild cognitive impairment in the Thai community-dwelling patients
מאת: Pongthanaracht N, et al.
יצא לאור: (2017-05-01)

Flavonoids as Inhibitors of Human Butyrylcholinesterase Variants
מאת: Maja Katalinić, et al.
יצא לאור: (2014-01-01)

Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?
מאת: Kehoe, P, et al.
יצא לאור: (2007)

Butyrylcholinesterase K variant associated with higher enzyme activity in the temporal cortex of elderly patients.
מאת: Tasker, A, et al.
יצא לאור: (2008)

Common variants of ACE contribute to variable age at onset of Alzheimer's disease
מאת: Katzov, H, et al.
יצא לאור: (2004)

Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism.
מאת: Katzov, H, et al.
יצא לאור: (2004)

The renin angiotensin system in Alzheimer's disease - Do updates high-light a clinical and biological dichotomy?
מאת: Kehoe, P, et al.
יצא לאור: (2006)

Obesity and variants of the GHRL (ghrelin) and BCHE (butyrylcholinesterase) genes
מאת: Vitor G.L. Dantas, et al.
יצא לאור: (2011-01-01)

Kinetics and computational study of butyrylcholinesterase inhibition by methylrosmarinate: relevance to Alzheimer’s disease treatment
מאת: Sani Muhammad Uzairu, et al.
יצא לאור: (2022-09-01)

Butyrylcholinesterase K variant on chromosome 3 q is associated with Type II diabetes in white Caucasian subjects.
מאת: Hashim, Y, et al.
יצא לאור: (2001)

Tumour necrosis factor-alpha gene polymorphisms and Alzheimer's disease.
מאת: Culpan, D, et al.
יצא לאור: (2003)

Benzene-1,3-diol derivatives as the inhibitors of butyrylcholinesterase: An emergent target of Alzheimer’s disease
מאת: Dongliang Yin, et al.
יצא לאור: (2022-01-01)

Aaptamine – a dual acetyl – and butyrylcholinesterase inhibitor as potential anti-Alzheimer’s disease agent
מאת: Shuang Miao, et al.
יצא לאור: (2022-12-01)

Butyrylcholinesterase Protein Ends in the Pathogenesis of Alzheimer’s Disease—Could <i>BCHE</i> Genotyping Be Helpful in Alzheimer’s Therapy?
מאת: Jacek Jasiecki, et al.
יצא לאור: (2019-10-01)

TNFR-associated factor-2 (TRAF-2) expression in Alzheimer's disease
מאת: Culpan, D, et al.
יצא לאור: (2004)

The relationship between CAV-1 and cerebral amyloid angiopathy in Alzheimer's disease
מאת: Chalmers, K, et al.
יצא לאור: (2004)

Widely Spread Butyrylcholinesterase Can Hydrolyze Acetylcholine in the Normal and Alzheimer Brain
מאת: Marsel Mesulam, et al.
יצא לאור: (2002-02-01)

Haplotypes extending across ACE are associated with Alzheimer's disease.
מאת: Kehoe, P, et al.
יצא לאור: (2003)

Novel anti-neuroinflammatory pyranone-carbamate derivatives as selective butyrylcholinesterase inhibitors for treating Alzheimer’s disease
מאת: Chuanyu Yu, et al.
יצא לאור: (2024-12-01)

Design, Synthesis and Biological Evaluation of Biscarbamates as Potential Selective Butyrylcholinesterase Inhibitors for the Treatment of Alzheimer’s Disease
מאת: Ana Matošević, et al.
יצא לאור: (2022-09-01)

Investigation of Association between Susceptibility to Leprosy and SNPs inside and near the BCHE Gene of Butyrylcholinesterase
מאת: Henrique J. P. Gomes, et al.
יצא לאור: (2012-01-01)

The ACE gene and Alzheimer's disease susceptibility.
מאת: Narain, Y, et al.
יצא לאור: (2000)

Biophenols of mints: Antioxidant, acetylcholinesterase, butyrylcholinesterase and histone deacetylase inhibition activities targeting Alzheimer’s disease treatment
מאת: Doaa M. Hanafy, et al.
יצא לאור: (2017-06-01)

Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors Based on the Pyridyl–Pyridazine Moiety for the Potential Treatment of Alzheimer’s Disease
מאת: Mohamed Elsawalhy, et al.
יצא לאור: (2024-10-01)

Correction: Evolution of Acetylcholinesterase and Butyrylcholinesterase in the Vertebrates: An Atypical Butyrylcholinesterase from the Medaka.
מאת: Leo Pezzementi, et al.
יצא לאור: (2011-01-01)

Treating Alzheimer's disease.
מאת: Wilcock, G, et al.
יצא לאור: (1995)

Evolution of acetylcholinesterase and butyrylcholinesterase in the vertebrates: an atypical butyrylcholinesterase from the Medaka Oryzias latipes.
מאת: Leo Pezzementi, et al.
יצא לאור: (2011-02-01)

Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy.
מאת: Miners, J, et al.
יצא לאור: (2006)

Protein and gene expression of tumour necrosis factor receptors I and II and their promoter gene polymorphisms in Alzheimer's disease.
מאת: Culpan, D, et al.
יצא לאור: (2007)